Anosys Inc.
This article was originally published in Start Up
Executive Summary
As a former head of discovery research at Rhone-Poulenc Rorer Inc. (now Aventis SA), Jean-Bernard Le Pecq, PhD was accustomed to learning of new discoveries on a regular basis. But in 1997, one particular breakthrough in cell-to-cell communications caught his attention. Researchers found that small vesicles, known as exosomes, allow for the transfer of proteins to other cells. Le Pecq believed that exosomes could be used as a mechanism to develop innovative therapeutic vaccines and this idea ultimately propelled him to co-found Anosys Inc. in 1997.